Who owns ASPIRE BIOPHARMA HLDGS INC WT EXP 021430?
- Ticker: ASBPW
- CUSIP Number: 738920115
Tip: Access positions for across all investors
Analyze quarterly positions in Aspire Biopharma Hldgs Inc Wt Exp 021430 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aspire Biopharma Hldgs Inc Wt Exp 021430 stock
Who bought or sold ASPIRE BIOPHARMA HLDGS INC WT EXP 021430 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Adage Capital Partners GP | 1.1M | $31k | 0% | Sep 2025 |
|
| Saba Capital Management | 984k | $29k | 0% | Sep 2025 |
|
| Linden Advisors | 900k | $25k | 0% | Sep 2025 |
|
| Aristeia Capital | 682k | $19k | 0% | Sep 2025 |
|
| Highbridge Capital Management | 554k | $17k | -47% | Sep 2025 |
|
| Toronto-Dominion Bank | 517k | $16k | 0% | Sep 2025 |
|
| OZ Management | 500k | $14k | 0% | Sep 2025 |
|
| Verition Fund Management | 433k | $13k | 0% | Sep 2025 |
|
| Barclays | 350k | $11k | 0% | Sep 2025 |
|
| Clear Street | 331k | $15k | 0% | Jun 2025 |
|
| Millennium Management | 275k | $8.2k | 0% | Sep 2025 |
|
| Alberta Investment Management Corporation | 250k | $7.5k | 0% | Sep 2025 |
|
| Antara Capital | 208k | $6.2M | 100% | Sep 2025 |
|
| D. E. Shaw & Co | 200k | $6.0k | 0% | Sep 2025 |
|
| Wolverine Asset Management | 197k | $5.9k | 1% | Sep 2025 |
|
| Context Capital Management | 175k | $5.2k | 0% | Sep 2025 |
|
| Nomura Holdings | 150k | $4.5k | 0% | Sep 2025 |
|
| Polar Securities | 139k | $3.9k | 0% | Sep 2025 |
|
| LMR Partners | 125k | $3.7k | 0% | Sep 2025 |
|
| Periscope Capital | 125k | $3.7k | 0% | Sep 2025 |
|
| Whitebox Advisors | 119k | $3.6k | 0% | Sep 2025 |
|
| Clear Street Derivatives | 106k | $4.7M | 0% | Jun 2025 |
|
| Jpmorgan Chase & Co | 100k | $3.0k | 0% | Sep 2025 |
|
| VR Advisory Services | 100k | $3.0k | 0% | Sep 2025 |
|
| Limestone Investment Advisors | 75k | $2.2k | 100% | Sep 2025 |
|
| Susquehanna International | 58k | $1.7k | 100% | Sep 2025 |
|
| Picton Mahoney Asset Management | 50k | $1.0k | 0% | Sep 2025 |
|
| Blue Owl Capital Holdings | 50k | $1.5k | 0% | Sep 2025 |
|
| Crossingbridge Advisors | 50k | $2.8k | 100% | Sep 2025 |
|
| OMERS Administration Corporation | 25k | $747.500000 | 0% | Sep 2025 |
|
| Mint Tower Capital Management B.V. | 25k | $5.0k | 0% | Sep 2025 |
|
| Flow Traders US | 15k | $0 | 3% | Sep 2025 |
|
| Advisor Group Holdings | 50.00 | $1.000000 | 0% | Sep 2025 |
|
| Investors Research Corp | 10.00 | $0 | 0% | Sep 2025 |
|
Who sold out of Aspire Biopharma Hldgs Inc Wt Exp 021430?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Taconic Capital Advisors | Jun 2025 | 300k | $13k |
| Athos Capital | Jun 2025 | 21k | $6.0k |